Suppr超能文献

睾丸生殖细胞肿瘤男性患者中缺乏致病性种系DICER1变异体。

Lack of pathogenic germline DICER1 variants in males with testicular germ-cell tumors.

作者信息

Vasta Lauren M, McMaster Mary L, Harney Laura A, Ling Alexander, Kim Jung, Harris Anne K, Carr Ann G, Damrauer Scott M, Rader Daniel J, Kember Rachel L, Kanetsky Peter A, Nathanson Katherine L, Pyle Louise C, Greene Mark H, Schultz Kris Ann, Stewart Douglas R

机构信息

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA; National Capital Consortium, Walter Reed National Military Medical Center, Bethesda, MD, USA.

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA; Commissioned Corps of the United States Public Health Service.

出版信息

Cancer Genet. 2020 Oct;248-249:49-56. doi: 10.1016/j.cancergen.2020.10.002. Epub 2020 Oct 24.

Abstract

BACKGROUND

Several studies have reported conflicting evidence on the inclusion of testicular germ cell tumors (TGCT) in the DICER1 tumor-predisposition phenotype. We evaluated the relationship between DICER1 and TGCT by reviewing scrotal ultrasounds of males with pathogenic germline variants in DICER1 and queried exome data from TGCT-affected men for DICER1 variants.

METHODOLOGY

Fifty-four male DICER1-carriers and family controls (n=41) enrolled in the National Cancer Institute (NCI) DICER1 Natural History Study were offered scrotal ultrasounds. These studies were examined by a single radiologist for abnormalities. In parallel, DICER1 variants from two large exome-sequenced TGCT cohorts were extracted. We used previously published AMG-AMP criteria to characterize rare DICER1 variants.

RESULTS

There was no observed difference in frequency of testicular cystic structures in DICER1-carriers versus controls. DICER1 variation was not associated with TGCT in the NCI DICER1-carriers. In 1,264 exome-sequenced men with TGCT, none harbored ClinVar- or InterVar-determined pathogenic or likely pathogenic variants in DICER1. Three DICER1 variants of uncertain significance (one case and two controls) were predicted "damaging" based on a priori criteria.

CONCLUSION

Using two complementary approaches, we found no evidence of an association between pathogenic DICER1 variants and TGCT.

摘要

背景

多项研究报告了关于睾丸生殖细胞肿瘤(TGCT)是否纳入DICER1肿瘤易感性表型的相互矛盾的证据。我们通过回顾携带DICER1致病种系变异男性的阴囊超声检查,并查询受TGCT影响男性的外显子组数据以寻找DICER1变异,评估了DICER1与TGCT之间的关系。

方法

参加美国国立癌症研究所(NCI)DICER1自然史研究的54名携带DICER1的男性及其家族对照(n = 41)接受了阴囊超声检查。这些检查由一名放射科医生进行异常检查。同时,从两个大型外显子组测序的TGCT队列中提取DICER1变异。我们使用先前发表的AMG-AMP标准来表征罕见的DICER1变异。

结果

在携带DICER1的个体与对照中,未观察到睾丸囊性结构频率的差异。在NCI携带DICER1的个体中,DICER1变异与TGCT无关。在1264名经外显子组测序的TGCT男性中,没有人携带ClinVar或InterVar确定的DICER1致病或可能致病变异。根据先验标准,三个意义未明的DICER1变异(1例病例和2例对照)被预测为“有害”。

结论

通过两种互补方法,我们未发现致病DICER1变异与TGCT之间存在关联的证据。

相似文献

6
Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1.DICER1 种系致病性变异个体的肿瘤风险。
J Clin Oncol. 2019 Mar 10;37(8):668-676. doi: 10.1200/JCO.2018.78.4678. Epub 2019 Feb 4.
8
The prevalence of DICER1 pathogenic variation in population databases.人群数据库中DICER1致病变异的患病率。
Int J Cancer. 2017 Nov 15;141(10):2030-2036. doi: 10.1002/ijc.30907. Epub 2017 Aug 21.

本文引用的文献

1
Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1.DICER1 种系致病性变异个体的肿瘤风险。
J Clin Oncol. 2019 Mar 10;37(8):668-676. doi: 10.1200/JCO.2018.78.4678. Epub 2019 Feb 4.
9
The prevalence of DICER1 pathogenic variation in population databases.人群数据库中DICER1致病变异的患病率。
Int J Cancer. 2017 Nov 15;141(10):2030-2036. doi: 10.1002/ijc.30907. Epub 2017 Aug 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验